David Hughes
Investigator · Sheffield Teaching Hospitals NHS Foundation Trust
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Hughes as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:49 UTC. Open this list on ClinicalTrials.gov
- N/ANCT02658201 · Ultrafast MRI Imaging to Exclude ConstipationSheffield Children's NHS Foundation Trust · completed · Constipation · principal investigator
- Ph4NCT01293292 · Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of ActionSheffield Teaching Hospitals NHS Foundation Trust · completed · Osteoporosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- The role of Fbxl22 in the regulation of skeletal muscle massK01AR077684 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · fiscal years 2021 to 2025 · $120,420 awarded in 2025Same name and institution; not confirmed by an ID
- The role of UBR5 in skeletal muscle atrophy and regrowthR03AR083980 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · fiscal years 2024 · $170,500 awarded in 2024Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:49 UTC. The ranking covers the 200 most relevant of 216 PubMed records, and a shared surname and initials can bring in a namesake. All 216 on PubMed
- Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.N Engl J Med · 2016430 citationsRCR 15.7
- Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.N Engl J Med · 2017317 citationsRCR 15.8
- Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.J Med Genet · 2017296 citationsRCR 11.7
- 259 citationsRCR 7.3
- 192 citationsRCR 7.5
- Metronidazole in prevention and treatment of bacteroides infections in elective colonic surgery.Br Med J · 1977191 citationsRCR 12.6
- 182 citationsRCR 8.3
- Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study.J Inherit Metab Dis · 2014176 citationsRCR 6.7
- 163 citationsRCR 14.7
- Social network targeting to maximise population behaviour change: a cluster randomised controlled trial.Lancet · 2015159 citationsRCR 6.9